The following is a summary of “Impact of impaired renal function on kinetics of high-sensitive cardiac troponin following ...

Male patients with inflammatory bowel disease (IBD) face a higher risk for ischemic heart diseases (IHDs), according to a ...

A wearable device that could detect sickness, such as chronic cardiovascular disease, is being developed by a Cincinnati professor.

With a healthy BMI, a good diet and healthy habits, Gail had an unlikely profile for a heart attack - which meant she was not ...

Interested parties may access the live webcast of the fireside chat by visiting the Investors & Media section of the Cytokinetics website at https://www.cytokinetics.com. The webcast replay will be ...

Edgewise Therapeutics , Inc. (NASDAQ:EWTX), with a market capitalization of $2.67 billion, is a biopharmaceutical company focused on developing innovative therapies for severe, rare muscle disorders.

A fitness instructor left hospital just three days after open-heart surgery and was running soon after, thanks to his ...

Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on January 31, 2025 it granted stock options to purchase an ...

After hours: January 28 at 6:00:33 p.m. EST ...

Friday marks Wear Red for Women Day, an initiative aimed at highlighting the importance of recognizing and addressing ...